<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">METHADONE HYDROCHLORIDE</span><br/>(meth'a-done)<br/><span class="topboxtradename">Dolophine, </span><span class="topboxtradename">Methadone<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">narcotic (opiate) agonist</span>; <span class="classification">analgesic</span><br/><b>Prototype: </b>Morphine<br/><b>Pregnancy Category: </b>B (D for use of high doses at term)<br/><b>Controlled Substance: </b>Schedule II<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>5 mg, 10 mg, 40 mg tablets; 5 mg/5 mL, 10 mg/5 mL, 10 mg/mL oral solution; 10 mg/mL injection</p>
<h1><a name="action">Actions</a></h1>
<p>Synthetic derivative similar to morphine but is orally effective and has longer duration of action. A single oral dose produces
         less sedation and euphoria than does morphine, but repeated doses produce marked sedation. Causes less constipation than morphine,
         but respiratory depressant effect and antitussive actions are comparable. Highly addictive, with abuse potential that matches
         that of morphine; abstinence syndrome develops more slowly; withdrawal symptoms are less intense but more prolonged.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Relieves severe pain and manages withdrawal therapy from narcotics.</p>
<h1><a name="uses">Uses</a></h1>
<p>To relieve severe pain; for detoxification and temporary maintenance treatment in hospital and in federally controlled maintenance
         programs for ambulatory patients with narcotic abstinence syndrome.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Obstetric analgesia. Safety during pregnancy (category B, category D for use of high doses at term), lactation, or for treatment
         of narcotic addiction in patients 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Liver, kidney, or cardiac dysfunction.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Moderate to Severe Acute Pain</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO/SC/IM</span> 2.510 mg q34h prn<br/><span class="rdage">Child:</span> <span class="rdroute">PO/IV</span> 0.1 mg/kg q4h times 23 doses, then q612h prn (max: 10 mg/dose)<br/><br/><span class="indicationtitle">Chronic Pain</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO/SC/IM</span> 520 mg q68h<br/><br/><span class="indicationtitle">Detoxification Treatment</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO/SC/IM</span> 1540 mg once/d, usually maintained at 20120 mg/d<br/><span class="rdage">Neonate:</span> <span class="rdroute">PO/IV</span> 0.050.2 mg/kg q1224h or 0.5 mg/kg/d divided q8h; taper dose by 1020%/wk over 11½ mo<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give for analgesic effect in the smallest effective dose to minimize the possible tolerance and physical and psychic dependence.</li>
<li>Dilute dispersible tablets in 120 mL of water or fruit juice and allow at least 1 min for dispersion.</li>
</ul><span class="adminroutetype">Subcutaneous/</span><span class="adminroutetype">Intramuscular</span><br/><ul>
<li> 					Note: IM route is preferred over SC when repeated parenteral administration is required (SC injections may cause local irritation
            and induration). Rotate injection sites. 				
         </li>
</ul>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><ul>
<li>Verify correct IV concentration and rate of infusion for administration to neonates, infants, children with physician.</li>
<li>IV route is used rarely. Get specific orders from physician.</li>
</ul>
<p><span class="routemethod">INCOMPATIBILITIES</span> <span class="incompattype">Solution/additive:</span> <b>Aminophylline,</b> <b>ammonium chloride,</b> <span class="classification">barbiturates</span>, <b>chlorothiazide,</b> <b>heparin,</b> <b>methicillin,</b> <b>phenytoin,</b> <b>sodium bicarbonate.</b>
</p>
</td>
</tr>
</table>
<ul>
<li>Store at 15°30° C (59°86° F) in tight, light-resistant containers.</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> <span class="speceff-common">Drowsiness,</span> light-headedness, dizziness, hallucinations. <span class="typehead">GI:</span> Nausea, vomiting, dry mouth, <span class="speceff-common">constipation.</span> <span class="typehead">Body as a Whole:</span> Transient fall in BP, bone and muscle pain. <span class="typehead">Urogenital:</span> Impotence. <span class="typehead">Respiratory:</span> <span class="speceff-life">Respiratory depression</span>. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> <b>Alcohol</b> and other <span class="classification">cns depressants</span>, <b>cimetidine</b> add to sedation and CNS depression; <span class="classification">amphetamines</span> may potentiate CNS stimulation; with <span class="classification">mao inhibitors</span>, <b>selegiline,</b> <b>furazolidone</b> causes excessive and prolonged CNS depression, convulsions, cardiovascular collapse. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Well absorbed from GI tract. <span class="typehead">Onset:</span> 3060 min PO; 1020 min IM/SC. <span class="typehead">Peak:</span> 12 h. <span class="typehead">Duration:</span> 68 h PO, IM, SC; may last 2248 h with chronic dosing. <span class="typehead">Distribution:</span> Crosses placenta; distributed into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead">Elimination:</span> Excreted in urine. <span class="typehead">Half-Life:</span> 1525 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Evaluate patient's continued need for methadone for pain. Adjustment of dosage and lengthening of between-dose intervals may
            be possible.
         </li>
<li>Monitor respiratory status. Principal danger of overdosage, as with morphine, is extreme respiratory depression.</li>
<li>Be aware that because of the cumulative effects of methadone, abstinence symptoms may not appear for 3672 h after last
            dose and may last 1014 d. Symptoms are usually of mild intensity (e.g., anorexia, insomnia, anxiety, abdominal discomfort,
            weakness, headache, sweating, hot and cold flashes).
         </li>
<li>Observe closely for recurrence of respiratory depression during use of narcotic antagonists such as naloxone, naltrexone,
            and levallorphan to terminate methadone intoxication. Since antagonist action is shorter (13 h) than that of methadone
            (3648 h or more), repeated doses for 824 h may be required.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Be aware that orthostatic hypotension, sweating, constipation, drowsiness, GI symptoms, and other transient adverse effects
            of therapeutic doses appear to be more prominent in ambulatory patients. Most adverse effects disappear over a period of several
            weeks.
         </li>
<li>Make position changes slowly, particularly from lying down to upright position; sit or lie down if you feel dizzy or faint.</li>
<li>Do not drive or engage in potentially hazardous activities until response to drug is known.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>